The RM Partners Medicines Optimisation workstream is working on areas both locally and across the Cancer Vanguard aimed at addressing and implementing the recommendations from the Independent Cancer Taskforce on improving access to chemotherapy and systemic medicines for cancer.
The Cancer Vanguard established a Joint Medicines Optimisation Group that includes representatives from each of the three local delivery systems. The main focus of the group is to oversee projects submitted to the Pharma Challenge. The challenge invited pharmaceutical companies to develop proposals for joint working with the NHS to improve the availability and delivery of cancer drugs.
Systemic Anti-Cancer Therapy Guidance
The London Cancer Alliance (LCA) produced standardised systemic anti-cancer therapy (SACT) protocols to be used across the LCA. Furthermore, the LCA also developed a number of educational and training materials for SACT healthcare professionals to raise standards across the network. These materials have been adopted by RM Partners and are still available for use.
The documents are due to be reviewed to ensure they are up-to-date and in line with the latest developments in medicines and national guidance.